Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer

NCT05736367 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: U-13C-glucose

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]